Fig. 2
From: Siglec-15: a potential regulator of osteoporosis, cancer, and infectious diseases
Glycan structures preferentially recognized by Siglec-15. a Sialyl-Tn (Neu5Acα2–6GalNAcα1-). b Non-natural glycan structure (Neu5Acα2–3[Neu5Acα2–6]Galβ1–4Glc/GlcNAcβ1-) preferentially recognized by Siglec-15 in Wu et al. [18]. c Sialylated and sulfated glycan structure (Neu5Acα2–3[HSO3–6]Galβ1–4GlcNAcβ1-) preferentially recognized by Siglec-8 [19]. d Non-natural glycan structures preferentially recognized by Siglec-15 in the study of Briard et al. [20]. Shown on the right are symbolic representations based on the Symbol Nomenclature for Glycans [21]